Anti-DGAT2L6 monoclonal antibody

Pre-made anti-DGAT2L6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DGAT2L6/DGAT2L6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0687-Ab-1/ GM-Tg-hg-IP0687-Ab-2Anti-Human DGAT2L6 monoclonal antibodyHuman
GM-Tg-rg-IP0687-Ab-1/ GM-Tg-rg-IP0687-Ab-2Anti-Rat DGAT2L6 monoclonal antibodyRat
GM-Tg-mg-IP0687-Ab-1/ GM-Tg-mg-IP0687-Ab-2Anti-Mouse DGAT2L6 monoclonal antibodyMouse
GM-Tg-cynog-IP0687-Ab-1/ GM-Tg-cynog-IP0687-Ab-2Anti-Cynomolgus/ Rhesus macaque DGAT2L6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0687-Ab-1/ GM-Tg-felg-IP0687-Ab-2Anti-Feline DGAT2L6 monoclonal antibodyFeline
GM-Tg-cang-IP0687-Ab-1/ GM-Tg-cang-IP0687-Ab-2Anti-Canine DGAT2L6 monoclonal antibodyCanine
GM-Tg-bovg-IP0687-Ab-1/ GM-Tg-bovg-IP0687-Ab-2Anti-Bovine DGAT2L6 monoclonal antibodyBovine
GM-Tg-equg-IP0687-Ab-1/ GM-Tg-equg-IP0687-Ab-2Anti-Equine DGAT2L6 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0687-Ab-1/ GM-Tg-hg-IP0687-Ab-2; GM-Tg-rg-IP0687-Ab-1/ GM-Tg-rg-IP0687-Ab-2;
GM-Tg-mg-IP0687-Ab-1/ GM-Tg-mg-IP0687-Ab-2; GM-Tg-cynog-IP0687-Ab-1/ GM-Tg-cynog-IP0687-Ab-2;
GM-Tg-felg-IP0687-Ab-1/ GM-Tg-felg-IP0687-Ab-2; GM-Tg-cang-IP0687-Ab-1/ GM-Tg-cang-IP0687-Ab-2;
GM-Tg-bovg-IP0687-Ab-1/ GM-Tg-bovg-IP0687-Ab-2; GM-Tg-equg-IP0687-Ab-1/ GM-Tg-equg-IP0687-Ab-2
Products NameAnti-DGAT2L6 monoclonal antibody
Formatmab
Target NameDGAT2L6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DGAT2L6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0687-Ag-1Recombinant multi-species DG2L6/ DGAT2L6/ DC3 protein


    Target information

    Target IDGM-IP0687
    Target NameDGAT2L6
    Gene ID347516,668257,678749,694889,607544,101100542,505958,100055603
    Gene Symbol and Synonyms9930021F22Rik,DC3,DGAT2L6
    Uniprot AccessionQ6ZPD8,A6QP72
    Uniprot Entry NameDG2L6_HUMAN,DG2L6_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184210
    Target ClassificationN/A

    The target: DGAT2L6, gene name: DGAT2L6, also named as DC3. This gene is a member of the diacylglycerol acyltransferase 2 family. The encoded protein is a putative acyltransferase and is most likely involved in the synthesis of di- or triacylglycerol, however its substrate specificity is currently unknown. [provided by RefSeq, Feb 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.